Your Location:
Home >
Browse articles >
Advances in management of acute promyelocytic leukemia with arsenic trioxide
OriginalPaper | Updated:2021-08-27
    • Advances in management of acute promyelocytic leukemia with arsenic trioxide

    • Advances in management of acute promyelocytic leukemia with arsenic trioxide

    • 中国结合医学杂志(英文版)   2007年13卷第2期 页码:92-94
    • DOI:10.1007/s11655-007-0092-y    

      中图分类号:
    • 纸质出版日期:2007,

    Scan for full text

  • Ma, J. Advances in management of acute promyelocytic leukemia with arsenic trioxide., Chin. J Integ. Med. 13, 92–94 (2007). https://doi.org/10.1007/s11655-007-0092-y DOI:

    Ma Jun. Advances in management of acute promyelocytic leukemia with arsenic trioxide[J]. Chinese Journal of Integrative Medicine, 2007,13(2):92-94. DOI: 10.1007/s11655-007-0092-y.

  •  
  •  
FULL TEXT LINK
More>

0

浏览量

367

Downloads

0

CSCD

文章被引用时,请邮件提醒。
Submit
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Integrative oncology meets immunotherapy: New prospects for combination therapy grounded in Eastern medical knowledge
Synergism between carnosic acid and arsenic trioxide on induction of acute myeloid leukemia cell apoptosis is associated with modulation of PTEN/Akt signaling pathway
Effect and prognostic analysis of treatment for acute myeloid leukemia using Chinese drugs combined with chemotherapy
Tanshinone IIA: a potent, natural anti-carcinogenic agent for the management of systemic malignancies
Effects of langchuangjing granule on apoptotic of CD4 + T and CD19 + B in spleen of BXSB mice with systemic lupus erythematosus

相关作者

暂无数据

相关机构

Department of Epidemiology, Mailman School of Public Health, Columbia University
Nuffield Department of Medicine and Department of Primary Health Care, University of Oxford
Global Initiative for Traditional Systems (GIFTS) of Health
Department of Health Care, Qilu Hospital of Shandong University
Department of Scientific Research, Qilu Hospital of Shandong University
0